Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Willis

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Nature Communications|July 18, 2024
Timing of whole genome duplication is associated with tumor-specific MHC-II depletion in serous ovarian cancerNikki L Burdett, Madelynne O Willis, Ahwan Pandey, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 31, 2026
Local Control With Moderately Hypofractionated Definitive Radiotherapy Delivered With a Simultaneous Integrated Boost Technique to Non-extremity Soft Tissue and Bone SarcomasJ D Towler, C David, O Willis, et al.
Journal of Thrombosis and Haemostasis : JTH|August 24, 2017
A novel protein C-factor VII chimera provides new insights into the structural requirements for cytoprotective protease-activated receptor 1 signalingE M Gleeson, C J McDonnell, E E Soule, et al.
Cell Death Discovery|September 25, 2025
Exploiting dysregulated iron homeostasis to eradicate persistent high-grade serous ovarian cancerCarmelo Cerra, Madeleine R C Tancock, Niko Thio, et al.
Nature Genetics|February 28, 2023
Multiomic analysis of homologous recombination-deficient end-stage high-grade serous ovarian cancerNikki L Burdett, Madelynne O Willis, Kathryn Alsop, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Nature Communications|July 18, 2024
Timing of whole genome duplication is associated with tumor-specific MHC-II depletion in serous ovarian cancerNikki L Burdett, Madelynne O Willis, Ahwan Pandey, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 31, 2026
Local Control With Moderately Hypofractionated Definitive Radiotherapy Delivered With a Simultaneous Integrated Boost Technique to Non-extremity Soft Tissue and Bone SarcomasJ D Towler, C David, O Willis, et al.
Journal of Thrombosis and Haemostasis : JTH|August 24, 2017
A novel protein C-factor VII chimera provides new insights into the structural requirements for cytoprotective protease-activated receptor 1 signalingE M Gleeson, C J McDonnell, E E Soule, et al.
Cell Death Discovery|September 25, 2025
Exploiting dysregulated iron homeostasis to eradicate persistent high-grade serous ovarian cancerCarmelo Cerra, Madeleine R C Tancock, Niko Thio, et al.
Nature Genetics|February 28, 2023
Multiomic analysis of homologous recombination-deficient end-stage high-grade serous ovarian cancerNikki L Burdett, Madelynne O Willis, Kathryn Alsop, et al.
Pageof 5